Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Dr. Reddy's Laboratories Ltd ADR (RDY)

Dr. Reddy's Laboratories Ltd ADR (RDY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Dr. Reddy's Laboratories Ltd ADR 8-2-337 ROAD NO.3 BANJARA HILLS HYDERABAD K7 500-034 IND

www.drreddys.com P: 91-40-4900-2900 F: 404-900-2999

Description:

Dr. Reddy's Laboratories Ltd. is an integrated global pharmaceutical company engaged in providing affordable and innovative medicines since 1984. The company markets its products in countries like the U.S., the UK, Germany, India, Russia, Venezuela, Romania and South Africa. Dr. Reddy's operates through three segments: Global Generics comprising unbranded prescription drugs along with over-the-counter drugs. It includes the operations of the company's biologics business. Pharmaceutical Services & Active Ingredients (PSAI) comprising active pharmaceutical ingredients (API) and custom pharmaceutical services. Proprietary Products and Others involving the new chemical entities, the differentiated formulations business and a dermatology specialty business. The company has a strategic partnership with Glaxo to market selected products across emerging markets outside India.

Key Statistics

Overview:

Market Capitalization, $K 12,066,586
Enterprise Value, $K 12,160,586
Shares Outstanding, K 166,873
Annual Sales, $ 2,992 M
Annual Net Income, $ 548,000 K
Last Quarter Sales, $ 865,780 K
Last Quarter Net Income, $ 165,470 K
EBIT, $ 776,290 K
EBITDA, $ 930,290 K
60-Month Beta 0.59
% of Insider Shareholders 2.00%
% of Institutional Shareholders 14.02%
Float, K 163,536
% Float 98.00%
Short Volume Ratio 0.73

Growth:

1-Year Return 30.80%
3-Year Return 16.95%
5-Year Return 83.60%
5-Year Revenue Growth 37.18%
5-Year Earnings Growth 226.73%
5-Year Dividend Growth 10.34%

Per-Share Information:

Most Recent Earnings 0.99 on 01/31/24
Latest Earnings Date 05/08/24
Earnings Per Share ttm 3.79
EPS Growth vs. Prev Qtr -7.48%
EPS Growth vs. Prev Year 8.79%
Annual Dividend Rate, $ 0.41
Annual Dividend Yield 0.57%
Most Recent Dividend 0.410 on 07/28/23
Next Ex-Dividends Date 07/28/23
Dividend Payable Date 08/11/23
Dividend Payout Ratio 10.81%
Most Recent Split 2-1 on 09/07/06

RDY Ratios

Ratio
Price/Earnings ttm 19.21
Price/Earnings forward 18.52
Price/Earnings to Growth 1.91
Return-on-Equity % 20.97%
Return-on-Assets % 15.19%
Profit Margin % 18.32%
Debt/Equity 0.07
Price/Sales 4.06
Price/Cash Flow 17.42
Price/Book 3.80
Book Value/Share 19.30
Interest Coverage 44.18

RDY Dividends

Date Value
07/28/23 $0.4100
07/07/23 $0.4140
08/01/22 $0.3170
07/08/22 $0.3250
07/30/21 $0.2850
07/08/21 $0.2800
07/10/20 $0.2740
07/12/19 $0.2620
07/13/18 $0.2720
07/13/17 $0.2900
07/14/16 $0.2770
07/08/15 $0.3117
08/01/14 $0.3034
07/09/14 $0.2830
07/10/13 $0.2644
06/27/12 $0.2294
06/29/11 $0.2508
06/14/11 $0.6522
06/30/10 $0.2395
07/02/09 $0.1313
07/03/08 $0.0976
07/06/07 $0.0921
07/07/06 $0.1086
07/07/05 $0.1146
07/15/04 $0.1087
08/07/03 $0.1074
08/08/02 $0.0511
11/20/01 $0.1000
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar